David A. Siegel Artivion, Inc. Transaction History
Two Sigma Advisers, LP
- $46.1 Billion
- Q2 2025
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Artivion, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 31,600 shares of AORT stock, worth $1.34 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
31,600
Previous 10,700
195.33%
Holding current value
$1.34 Million
Previous $263,000
273.38%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding AORT
# of Institutions
197Shares Held
40.2MCall Options Held
19.2KPut Options Held
0-
Black Rock Inc. New York, NY6.64MShares$281 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C32.96MShares$125 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.8MShares$118 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY2.79MShares$118 Million3.82% of portfolio
-
Morgan Stanley New York, NY2.32MShares$98.1 Million0.0% of portfolio
About ARTIVION, INC.
- Ticker AORT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 40,316,100
- Market Cap $1.71B
- Description
- Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...